Phase II Clinical Trial of Bryostatin-1, NSC 339555, and Cisplatin in Patients With Recurrent and/or Advanced Inoperable Squamous Cell, Adeno or Adenosquamous Cell Carcinoma of the Cervix
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2015
At a glance
- Drugs Bryostatin-1 (Primary) ; Cisplatin (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 03 Jul 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 11 Oct 2005 New trial record.